HDR UK Gateway
HDR Gateway logo

Bookmarks

ICON9 Trial

Population Size

Not reported
Population Size statistic card

Years

2018

Years statistic card

Associated BioSamples

Serum

Tissue

Associated BioSamples statistic card

Geographic coverage

United Kingdom

England

Geographic coverage statistic card

Lead time

Other

Lead time statistic card

Summary

Collection of samples and data across the following diseases: Malignant tumour of ovary

Documentation

An international phase III randomised study to evaluate the efficacy of maintenance cediranib and olaparib combination therapy or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

Dataset type

Health and disease

Keywords

Provenance

Image contrast

Not stated

Biological sample availability

Serum,Tissue

Details

Publishing frequency

Other

Version

1.0.0

Modified

08/10/2024

Citation Requirements

In Progress

Coverage

Start date

01/01/2018

Time lag

Variable

Geographic coverage

United Kingdom, England

Minimum age range

40

Maximum age range

150

Accessibility

Language

en

Controlled vocabulary

LOCAL

Format

In Progress

Data Access Request

Dataset pipeline status

Not available

Access rights

Please contact the publisher using Contact Point details provided

Time to dataset access

Other

Access request cost

Not specified

Access method category

Varies based on project

Data Controller

University College London

Dataset Types: Health and disease

Collection Sources: